Description
The PRIDE-2 study retrospectively evaluated the effectiveness and safety of an omeprazole–domperidone combination for managing acid peptic disease (APD) in patients with type 2 diabetes mellitus across multiple Indian healthcare settings (2018–2021).
Among 174 patients, significant improvement in symptoms was observed over 120 days & no serious adverse events were reported. The omeprazole–domperidone combination was effective and well tolerated, offering substantial symptomatic relief in diabetic patients with APD.